About Us

Working together to improve patient outcomes and reduce costs thorough novel arterial access site management technology

Andrzej Białkowski-Miler, CEO

Biotech & MedTech entrepreneur and consultant with over 16 years of experience in all stages of technology transfer and start-up development.

  • Founder and CEO at BMC/Biotech Management Consulting (boutique consultancy providing technology due dilligence and valuation services)
  • EMBA candidate, Chicago Booth
  • MS in Technology Commercialization University of Texas/ Łódź
  • MS in Biotechnology (honors)

Mariusz Kruk, Ph.D, CMO

Inventor, serial innovator and patent holder. Scientist, clinician, operator, and investigator, specialising in the optimization of new medical procedures and diagnostic methods.
  • >20 clinical trials within cardiology, invasive cardiology (role of PI)
  • >140 publications
  • Associate Professor at the National Institute
    of Cardiology
  • MD, PhD Cardiologist, Invasive cardiologist

Our Team

Advisory Board

Aligning science and experience to change outcomes in interventional cardiovascular procedures

  • Experienced team addressing clinical challenges every day
  • Clear vision of the future medical and patients needs
  • Comprehensive skills in-house
  • Outcomes driven approach
  • Innovation by clinical practice guided decisions

Scroll to Top